The Importance of Remnant Cholesterol in PAD: Hidden in Plain Sight.

COI Statement

Funding Support and Author Disclosures Dr Shapiro has received grant/research support (through his institution) from Amgen, Arrowhead, Boehringer Ingelheim, 89Bio, Esperion, Novartis, Ionis, Merck, New Amsterdam, Lilly, and Cleerly; has participated in Scientific Advisory Boards with Amgen, Arrowhead, Ionis, Novartis, New Amsterdam, and Merck; and has served as a consultant for Ionis, Novartis, Regeneron, Aidoc, Kaneka, Novo Nordisk, Arrowhead, and Tourmaline.